NDC 57894-514-01
Rybrevant Faspro 2240 mg/14mL
AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT) · INJECTION
Rybrevant Faspro is a injection containing amivantamab and hyaluronidase-lpuj (human recombinant) at a strength of 2240 mg/14mL. Manufactured by Janssen Biotech, Inc..
Key Facts
- Brand Name
- Rybrevant Faspro
- Generic Name
- AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT)
- NDC Code (Package)
57894-514-01- NDC Code (Product)
57894-514- Manufacturer
- Janssen Biotech, Inc.
- Strength
- 2240 mg/14mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761433
- Drug Class
- Endoglycosidase [EPC]
- Marketing Start
- 12/19/2025
Recall History
No Recall HistoryView Full Drug Page
Rybrevant Faspro — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.